                               SEQUENCE LISTING

<110> ALASTIN SKINCARE, INC.
 
<120> COMPOSITIONS AND METHODS RELATING TO PIGMENTATION

<130> 53936-708.601

<140> PCT/US2021/024400
<141> 2021-03-26

<150> 63/001,095
<151> 2020-03-27

<160> 26    

<170> PatentIn version 3.5

<210> 1
<211> 689
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 1
Ala Pro Arg Lys Asn Val Arg Trp Cys Thr Ile Ser Gln Pro Glu Trp 
1               5                   10                  15      


Phe Lys Cys Arg Arg Trp Gln Trp Arg Met Lys Lys Leu Gly Ala Pro 
            20                  25                  30          


Ser Ile Thr Cys Val Arg Arg Ala Phe Ala Leu Glu Cys Ile Arg Ala 
        35                  40                  45              


Ile Ala Glu Lys Lys Ala Asp Ala Val Thr Leu Asp Gly Gly Met Val 
    50                  55                  60                  


Phe Glu Ala Cys Arg Asp Pro Tyr Lys Leu Arg Pro Val Ala Ala Glu 
65                  70                  75                  80  


Ile Tyr Gly Thr Lys Glu Ser Pro Gln Thr His Tyr Tyr Ala Val Ala 
                85                  90                  95      


Val Val Lys Lys Gly Ser Asn Phe Gln Leu Asp Gln Leu Gln Gly Arg 
            100                 105                 110         


Lys Ser Cys His Thr Gly Leu Gly Arg Ser Ala Gly Trp Ile Ile Pro 
        115                 120                 125             


Met Gly Ile Leu Arg Pro Tyr Leu Ser Trp Thr Glu Ser Leu Glu Pro 
    130                 135                 140                 


Leu Gln Gly Ala Val Ala Lys Phe Phe Ser Ala Ser Cys Val Pro Cys 
145                 150                 155                 160 


Ile Asp Arg Gln Ala Tyr Pro Asn Leu Cys Gln Leu Cys Lys Gly Glu 
                165                 170                 175     


Gly Glu Asn Gln Cys Ala Cys Ser Ser Arg Glu Pro Tyr Phe Gly Tyr 
            180                 185                 190         


Ser Gly Ala Phe Lys Cys Leu Gln Asp Gly Ala Gly Asp Val Ala Phe 
        195                 200                 205             


Val Lys Glu Thr Thr Val Phe Glu Asn Leu Pro Glu Lys Ala Asp Arg 
    210                 215                 220                 


Asp Gln Tyr Glu Leu Leu Cys Leu Asn Asn Ser Arg Ala Pro Val Asp 
225                 230                 235                 240 


Ala Phe Lys Glu Cys His Leu Ala Gln Val Pro Ser His Ala Val Val 
                245                 250                 255     


Ala Arg Ser Val Asp Gly Lys Glu Asp Leu Ile Trp Lys Leu Leu Ser 
            260                 265                 270         


Lys Ala Gln Glu Lys Phe Gly Lys Asn Lys Ser Arg Ser Phe Gln Leu 
        275                 280                 285             


Phe Gly Ser Pro Pro Gly Gln Arg Asp Leu Leu Phe Lys Asp Ser Ala 
    290                 295                 300                 


Leu Gly Phe Leu Arg Ile Pro Ser Lys Val Asp Ser Ala Leu Tyr Leu 
305                 310                 315                 320 


Gly Ser Arg Tyr Leu Thr Thr Leu Lys Asn Leu Arg Glu Thr Ala Glu 
                325                 330                 335     


Glu Val Lys Ala Arg Tyr Thr Arg Val Val Trp Cys Ala Val Gly Pro 
            340                 345                 350         


Glu Glu Gln Lys Lys Cys Gln Gln Trp Ser Gln Gln Ser Gly Gln Asn 
        355                 360                 365             


Val Thr Cys Ala Thr Ala Ser Thr Thr Asp Asp Cys Ile Val Leu Val 
    370                 375                 380                 


Leu Lys Gly Glu Ala Asp Ala Leu Asn Leu Asp Gly Gly Tyr Ile Tyr 
385                 390                 395                 400 


Thr Ala Gly Lys Cys Gly Leu Val Pro Val Leu Ala Glu Asn Arg Lys 
                405                 410                 415     


Ser Ser Lys His Ser Ser Leu Asp Cys Val Leu Arg Pro Thr Glu Gly 
            420                 425                 430         


Tyr Leu Ala Val Ala Val Val Lys Lys Ala Asn Glu Gly Leu Thr Trp 
        435                 440                 445             


Asn Ser Leu Lys Asp Lys Lys Ser Cys His Thr Ala Val Asp Arg Thr 
    450                 455                 460                 


Ala Gly Trp Asn Ile Pro Met Gly Leu Ile Val Asn Gln Thr Gly Ser 
465                 470                 475                 480 


Cys Ala Phe Asp Glu Phe Phe Ser Gln Ser Cys Ala Pro Gly Ala Asp 
                485                 490                 495     


Pro Lys Ser Arg Leu Cys Ala Leu Cys Ala Gly Asp Asp Gln Gly Leu 
            500                 505                 510         


Asp Lys Cys Val Pro Asn Ser Lys Glu Lys Tyr Tyr Gly Tyr Thr Gly 
        515                 520                 525             


Ala Phe Arg Cys Leu Ala Glu Asp Val Gly Asp Val Ala Phe Val Lys 
    530                 535                 540                 


Asn Asp Thr Val Trp Glu Asn Thr Asn Gly Glu Ser Thr Ala Asp Trp 
545                 550                 555                 560 


Ala Lys Asn Leu Asn Arg Glu Asp Phe Arg Leu Leu Cys Leu Asp Gly 
                565                 570                 575     


Thr Arg Lys Pro Val Thr Glu Ala Gln Ser Cys His Leu Ala Val Ala 
            580                 585                 590         


Pro Asn His Ala Val Val Ser Arg Ser Asp Arg Ala Ala His Val Lys 
        595                 600                 605             


Gln Val Leu Leu His Gln Gln Ala Leu Phe Gly Lys Asn Gly Lys Asn 
    610                 615                 620                 


Cys Pro Asp Lys Phe Cys Leu Phe Lys Ser Glu Thr Lys Asn Leu Leu 
625                 630                 635                 640 


Phe Asn Asp Asn Thr Glu Cys Leu Ala Lys Leu Gly Gly Arg Pro Thr 
                645                 650                 655     


Tyr Glu Glu Tyr Leu Gly Thr Glu Tyr Val Thr Ala Ile Ala Asn Leu 
            660                 665                 670         


Lys Lys Cys Ser Thr Ser Pro Leu Leu Glu Ala Cys Ala Phe Leu Thr 
        675                 680                 685             


Arg 
    


<210> 2
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Pro Arg Lys Asn Val Arg Trp Cys Thr 
1               5                   


<210> 3
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Leu Gly Phe Leu Arg Ile Pro 
1               5           


<210> 4
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Gly Tyr Ser Gly Ala Phe Lys Cys 
1               5               


<210> 5
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Thr Cys Val Arg Arg 
1               5   


<210> 6
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Thr Cys Val Arg Arg Ala Phe 
1               5           


<210> 7
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Trp Asn Ser Leu Lys Asp Lys Lys Ser Cys His 
1               5                   10      


<210> 8
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Leu Phe Asn Asp Asn Thr Glu Cys Leu Ala Lys Leu Gly 
1               5                   10              


<210> 9
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Thr Thr Leu Lys Asn Leu Arg 
1               5           


<210> 10
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Gln Gly Leu Asp Lys Cys Val Pro Asn Ser Lys Glu 
1               5                   10          


<210> 11
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Val Lys Lys Ala Asn Glu 
1               5       


<210> 12
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Leu Ala Lys Leu Gly Gly Arg Pro 
1               5               


<210> 13
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Gly Asp Val Ala Phe Val Lys 
1               5           


<210> 14
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Asn Leu Asn Arg Glu Asp Phe Arg Leu 
1               5                   


<210> 15
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Ala Leu Gly Phe Leu Arg Ile 
1               5           


<210> 16
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Thr Thr Leu Lys Asn Leu Arg 
1               5           


<210> 17
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Asp Ala Leu Asn Leu Asp Gly 
1               5           


<210> 18
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Leu Ala Glu Asp Val 
1               5   


<210> 19
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Arg Ala Phe Ala Leu Glu Cys 
1               5           


<210> 20
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
Gly Ala Val Ala Lys Phe Phe Ser 
1               5               


<210> 21
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 21
Asn Leu Arg Glu Thr Ala 
1               5       


<210> 22
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 22
Glu Glu Gln Lys Lys Cys 
1               5       


<210> 23
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 23
Cys Val Pro Asn Ser Lys Glu Lys Tyr 
1               5                   


<210> 24
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 24
Gln Ala Tyr Pro Asn Leu 
1               5       


<210> 25
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term palmitoyl

<400> 25
Val Gly Val Ala Pro Gly 
1               5       


<210> 26
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term myristoyl

<400> 26
Val Gly Val Ala Pro Gly 
1               5       


